30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

HTG Molecular Diagnostics Inc (HTGM)

Track

Stock chart
Ticker: HTGM Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Barat Stephen
Senior VP of Therapeutics
1 sale — total 710 USD
Sale 8 Jun 2023
Value US$535,898.88 | Price 433.16 | Shares 17,218
Planned sale 26 Dec 2019
Value US$3,112,149.62 | Price 28.37 | Shares 85,925
Planned sale 1 Dec 2017
Value US$1,992.15 | Price 2.11 | Shares 945
Planned sale 1 Nov 2017
Value US$2,135.70 | Price 2.26 | Shares 945
Planned sale 16 Oct 2017
Value US$2,148.27 | Price 2.27 | Shares 946
Sale 25 Aug 2017
Value US$1,260,590.56 | Price 1.75 | Shares 720,214
Sale 24 Aug 2017
Value US$729,919.26 | Price 1.91 | Shares 382,437
Sale 23 Aug 2017
Value US$95,474.75 | Price 2.02 | Shares 47,162
Sale 22 Aug 2017
Value US$25,412.20 | Price 2.01 | Shares 12,641
Sale 21 Aug 2017
Value US$25,976.44 | Price 2.02 | Shares 12,845
Sale 18 Aug 2017
Value US$115,599.80 | Price 2.10 | Shares 55,100
Sale 27 Mar 2017
Value US$3,045,180.00 | Price 10.15 | Shares 300,000
Planned sale 4 Apr 2016
Value US$535.02 | Price 2.92 | Shares 183
Planned sale 4 Apr 2016
Value US$1,572.90 | Price 2.92 | Shares 538
Planned sale 4 Apr 2016
Value US$511.63 | Price 2.92 | Shares 175
Planned sale 4 Apr 2016
Value US$254.35 | Price 2.92 | Shares 87
Planned sale 1 Apr 2016
Value US$4,301.42 | Price 2.89 | Shares 1,489
Planned sale 1 Apr 2016
Value US$12,641.39 | Price 2.89 | Shares 4,376
Planned sale 1 Apr 2016
Value US$4,119.43 | Price 2.89 | Shares 1,426
Planned sale 1 Apr 2016
Value US$2,048.16 | Price 2.89 | Shares 709
Planned sale 14 Mar 2016
Value US$238.33 | Price 2.19 | Shares 109
Planned sale 14 Mar 2016
Value US$238.33 | Price 2.19 | Shares 109
Planned sale 14 Mar 2016
Value US$273.31 | Price 2.19 | Shares 125
Planned sale 14 Mar 2016
Value US$247.07 | Price 2.19 | Shares 113
Planned sale 14 Mar 2016
Value US$242.70 | Price 2.19 | Shares 111
Planned sale 11 Mar 2016
Value US$9,928.01 | Price 2.36 | Shares 4,215
Planned sale 11 Mar 2016
Value US$10,140.00 | Price 2.36 | Shares 4,305
Planned sale 11 Mar 2016
Value US$19,205.93 | Price 2.36 | Shares 8,154
Planned sale 11 Mar 2016
Value US$12,398.83 | Price 2.36 | Shares 5,264
Planned sale 11 Mar 2016
Value US$10,646.41 | Price 2.36 | Shares 4,520
Planned sale 10 Mar 2016
Value US$3,015.75 | Price 2.49 | Shares 1,211
Planned sale 10 Mar 2016
Value US$3,080.50 | Price 2.49 | Shares 1,237
Planned sale 10 Mar 2016
Value US$5,832.28 | Price 2.49 | Shares 2,342
Planned sale 10 Mar 2016
Value US$3,765.33 | Price 2.49 | Shares 1,512
Planned sale 10 Mar 2016
Value US$3,232.41 | Price 2.49 | Shares 1,298
Planned sale 9 Mar 2016
Value US$8,933.28 | Price 2.69 | Shares 3,325
Planned sale 9 Mar 2016
Value US$16,923.52 | Price 2.69 | Shares 6,299
Planned sale 9 Mar 2016
Value US$10,926.81 | Price 2.69 | Shares 4,067
Planned sale 9 Mar 2016
Value US$9,379.27 | Price 2.69 | Shares 3,491
Planned sale 9 Mar 2016
Value US$8,747.90 | Price 2.69 | Shares 3,256
Buy 24 Aug 2015
Value US$5,341.20 | Price 5.34 | Shares 1,000
Buy 24 Aug 2015
Value US$5,160.00 | Price 5.16 | Shares 1,000
Buy 18 Aug 2015
Value US$33,350.00 | Price 5.75 | Shares 5,800
Buy 18 Aug 2015
Value US$583.20 | Price 5.83 | Shares 100
Buy 18 Aug 2015
Value US$2,336.00 | Price 5.84 | Shares 400
Buy 18 Aug 2015
Value US$1,166.00 | Price 5.83 | Shares 200
Buy 12 Aug 2015
Value US$2,193.00 | Price 7.31 | Shares 300
Buy 12 Aug 2015
Value US$2,238.00 | Price 7.46 | Shares 300
Buy 12 Aug 2015
Value US$15,240.00 | Price 7.62 | Shares 2,000
Buy 12 Aug 2015
Value US$17,952.00 | Price 7.48 | Shares 2,400
Buy 12 Aug 2015
Value US$4,875.00 | Price 7.50 | Shares 650
Buy 11 Aug 2015
Value US$105.00 | Price 7.50 | Shares 14
Buy 11 Aug 2015
Value US$38,242.62 | Price 7.67 | Shares 4,986
Buy 11 May 2015
Value US$1,434,230.00 | Price 14.00 | Shares 102,445
Buy 11 May 2015
Value US$2,342,802.00 | Price 14.00 | Shares 167,343
Buy 11 May 2015
Value US$5,111,484.00 | Price 14.00 | Shares 365,106
Buy 11 May 2015
Value US$5,111,484.00 | Price 14.00 | Shares 365,106
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-06-09 2023-06-08 S Sale
Barat Stephen

Senior VP of Therapeutics

Officer
17,218 +27.9%
433.16
US$535,899 		17,218 +27.9% 433.16 US$535,899
2020-01-02 2019-12-26 PlS Planned sale
JOHNSON TIM B

Executive Chairman

Executive Director
85,925 -24.1%
28.37
US$3,112,150 		85,925 -24.1% 28.37 US$3,112,150
2017-12-01 2017-12-01 PlS Planned sale McMeans Shaun D

VP, Finance & Admin. & CFO
98,011 +8.0%
380.89
US$64,132 		98,011 +8.0% 380.89 US$64,132
2017-11-03 2017-11-01 PlS Planned sale McMeans Shaun D

VP, Finance & Admin. & CFO
945 -2.1%
2.26
US$2,136 		945 -2.1% 2.26 US$2,136
2017-10-18 2017-10-16 PlS Planned sale McMeans Shaun D

VP, Finance & Admin. & CFO
946 -2.1%
2.27
US$2,148 		946 -2.1% 2.27 US$2,148
2017-08-25 2017-08-25 S Sale Novo Holdings A/S Large shareholder
720,214 -100.0%
1.75
US$1,260,591 		720,214 -100.0% 1.75 US$1,260,591
2017-08-25 2017-08-24 S Sale Novo Holdings A/S Large shareholder
382,437 -34.7%
1.91
US$729,919 		382,437 -34.7% 1.91 US$729,919
2017-08-25 2017-08-23 S Sale Novo Holdings A/S Large shareholder
47,162 -4.1%
2.02
US$95,475 		47,162 -4.1% 2.02 US$95,475
2017-08-22 2017-08-22 S Sale Novo Holdings A/S Large shareholder
12,641 -1.0%
2.01
US$25,412 		12,641 -1.0% 2.01 US$25,412
2017-08-22 2017-08-21 S Sale Novo Holdings A/S Large shareholder
12,845 -1.0%
2.02
US$25,976 		12,845 -1.0% 2.02 US$25,976
2017-08-22 2017-08-18 S Sale Novo Holdings A/S Large shareholder
55,100 -4.3%
2.10
US$115,600 		55,100 -4.3% 2.10 US$115,600
2017-03-29 2017-03-27 S Sale GLAXOSMITHKLINE PLC
300,000 -27.5%
10.15
US$3,045,180 		300,000 -27.5% 10.15 US$3,045,180
2016-04-05 2016-04-04 PlS Planned sale Gordon Debra A

V.P. and Chief Legal Counsel

Officer
183 -1.0%
2.92
US$535 		183 -1.0% 2.92 US$535
2016-04-05 2016-04-04 PlS Planned sale
JOHNSON TIM B

President & CEO

Executive Director
538 -1.0%
2.92
US$1,573 		538 -1.0% 2.92 US$1,573
2016-04-05 2016-04-04 PlS Planned sale
McMeans Shaun D

VP, Finance & Admin. & CFO

Officer
175 -0.9%
2.92
US$512 		175 -0.9% 2.92 US$512
2016-04-05 2016-04-04 PlS Planned sale Lubniewski John L

Chief Business Officer

Officer
87 -0.3%
2.92
US$254 		87 -0.3% 2.92 US$254
2016-04-05 2016-04-01 PlS Planned sale
Gordon Debra A

V.P. and Chief Legal Counsel

Officer
1,489 -7.8%
2.89
US$4,301 		1,489 -7.8% 2.89 US$4,301
2016-04-05 2016-04-01 PlS Planned sale
JOHNSON TIM B

President & CEO

Executive Director
4,376 -7.9%
2.89
US$12,641 		4,376 -7.9% 2.89 US$12,641
2016-04-05 2016-04-01 PlS Planned sale
McMeans Shaun D

VP, Finance & Admin. & CFO

Officer
1,426 -6.6%
2.89
US$4,119 		1,426 -6.6% 2.89 US$4,119
2016-04-05 2016-04-01 PlS Planned sale Lubniewski John L

Chief Business Officer

Officer
709 -2.7%
2.89
US$2,048 		709 -2.7% 2.89 US$2,048
2016-03-14 2016-03-14 PlS Planned sale
Gordon Debra A

V.P. and Chief Legal Counsel

Officer
109 -0.6%
2.19
US$238 		109 -0.6% 2.19 US$238
2016-03-14 2016-03-14 PlS Planned sale
McMeans Shaun D

VP, Finance & Admin. & CFO

Officer
109 -0.5%
2.19
US$238 		109 -0.5% 2.19 US$238
2016-03-14 2016-03-14 PlS Planned sale
JOHNSON TIM B

President & CEO

Executive Director
125 -0.2%
2.19
US$273 		125 -0.2% 2.19 US$273
2016-03-14 2016-03-14 PlS Planned sale
Lubniewski John L

Chief Business Officer

Officer
113 -0.4%
2.19
US$247 		113 -0.4% 2.19 US$247
2016-03-14 2016-03-14 PlS Planned sale
Roche Patrick C.

SVP Research & Development

Officer
111 -0.6%
2.19
US$243 		111 -0.6% 2.19 US$243
2016-03-14 2016-03-11 PlS Planned sale
Gordon Debra A

V.P. and Chief Legal Counsel

Officer
4,215 -17.9%
2.36
US$9,928 		4,215 -17.9% 2.36 US$9,928
2016-03-14 2016-03-11 PlS Planned sale
McMeans Shaun D

VP, Finance & Admin. & CFO

Officer
4,305 -16.6%
2.36
US$10,140 		4,305 -16.6% 2.36 US$10,140
2016-03-14 2016-03-11 PlS Planned sale JOHNSON TIM B

President & CEO

Executive Director
8,154 -12.7%
2.36
US$19,206 		8,154 -12.7% 2.36 US$19,206
2016-03-14 2016-03-11 PlS Planned sale
Lubniewski John L

Chief Business Officer

Officer
5,264 -16.9%
2.36
US$12,399 		5,264 -16.9% 2.36 US$12,399
2016-03-14 2016-03-11 PlS Planned sale
Roche Patrick C.

SVP Research & Development

Officer
4,520 -19.0%
2.36
US$10,646 		4,520 -19.0% 2.36 US$10,646
2016-03-14 2016-03-10 PlS Planned sale Gordon Debra A

V.P. and Chief Legal Counsel

Officer
1,211 -4.9%
2.49
US$3,016 		1,211 -4.9% 2.49 US$3,016
2016-03-14 2016-03-10 PlS Planned sale McMeans Shaun D

VP, Finance & Admin. & CFO

Officer
1,237 -4.5%
2.49
US$3,081 		1,237 -4.5% 2.49 US$3,081
2016-03-14 2016-03-10 PlS Planned sale
JOHNSON TIM B

President & CEO

Executive Director
2,342 -3.5%
2.49
US$5,832 		2,342 -3.5% 2.49 US$5,832
2016-03-14 2016-03-10 PlS Planned sale
Lubniewski John L

Chief Business Officer

Officer
1,512 -4.6%
2.49
US$3,765 		1,512 -4.6% 2.49 US$3,765
2016-03-14 2016-03-10 PlS Planned sale
Roche Patrick C.

SVP Research & Development

Officer
1,298 -5.2%
2.49
US$3,232 		1,298 -5.2% 2.49 US$3,232
2016-03-09 2016-03-09 PlS Planned sale
McMeans Shaun D

VP, Finance & Admin. & CFO

Officer
3,325 -10.9%
2.69
US$8,933 		3,325 -10.9% 2.69 US$8,933
2016-03-09 2016-03-09 PlS Planned sale
JOHNSON TIM B

President & CEO

Executive Director
6,299 -8.7%
2.69
US$16,924 		6,299 -8.7% 2.69 US$16,924
2016-03-09 2016-03-09 PlS Planned sale
Lubniewski John L

Chief Business Officer

Officer
4,067 -11.1%
2.69
US$10,927 		4,067 -11.1% 2.69 US$10,927
2016-03-09 2016-03-09 PlS Planned sale
Roche Patrick C.

SVP Research & Development

Officer
3,491 -12.2%
2.69
US$9,379 		3,491 -12.2% 2.69 US$9,379
2016-03-09 2016-03-09 PlS Planned sale
Gordon Debra A

V.P. and Chief Legal Counsel

Officer
3,256 -11.6%
2.69
US$8,748 		3,256 -11.6% 2.69 US$8,748
2015-08-25 2015-08-24 B Purchase JOHNSON TIM B

President & CEO

Executive Director
1,000 +9.3%
5.34
US$5,341 		1,000 +9.3% 5.34 US$5,341
2015-08-24 2015-08-24 B Purchase Gordon Debra A

V.P. and Chief Legal Counsel

Officer
1,000 +280.9%
5.16
US$5,160 		1,000 +280.9% 5.16 US$5,160
2015-08-19 2015-08-18 B Purchase Roche Patrick C.

SVP Research & Development

Officer
5,800 +828.6%
5.75
US$33,350 		5,800 +828.6% 5.75 US$33,350
2015-08-19 2015-08-18 B Purchase Roche Patrick C.

SVP Research & Development

Officer
100 +16.7%
5.83
US$583 		100 +16.7% 5.83 US$583
2015-08-19 2015-08-18 B Purchase Roche Patrick C.

SVP Research & Development

Officer
400 +200.0%
5.84
US$2,336 		400 +200.0% 5.84 US$2,336
2015-08-19 2015-08-18 B Purchase Roche Patrick C.

SVP Research & Development

Officer
200 +inf%
5.83
US$1,166 		200 +inf% 5.83 US$1,166
2015-08-13 2015-08-12 B Purchase JOHNSON TIM B

President & CEO

Executive Director
300 +2.9%
7.31
US$2,193 		300 +2.9% 7.31 US$2,193
2015-08-13 2015-08-12 B Purchase JOHNSON TIM B

President & CEO

Executive Director
300 +3.0%
7.46
US$2,238 		300 +3.0% 7.46 US$2,238
2015-08-13 2015-08-12 B Purchase JOHNSON TIM B

President & CEO

Executive Director
2,000 +24.6%
7.62
US$15,240 		2,000 +24.6% 7.62 US$15,240
2015-08-13 2015-08-12 B Purchase JOHNSON TIM B

President & CEO

Executive Director
2,400 +42.0%
7.48
US$17,952 		2,400 +42.0% 7.48 US$17,952
2015-08-12 2015-08-12 B Purchase McMeans Shaun D

VP, Finance & Admin. & CFO

Officer
650 +22.9%
7.50
US$4,875 		650 +22.9% 7.50 US$4,875
2015-08-12 2015-08-11 B Purchase Lubniewski John L

Chief Business Officer

Officer
14 +0.2%
7.50
US$105 		14 +0.2% 7.50 US$105
2015-08-12 2015-08-11 B Purchase Lubniewski John L

Chief Business Officer

Officer
4,986 +139.6%
7.67
US$38,243 		4,986 +139.6% 7.67 US$38,243
2015-05-13 2015-05-11 B Purchase Fletcher Spaght Ventures II LP Large shareholder
102,445 +24.6%
14.00
US$1,434,230 		102,445 +24.6% 14.00 US$1,434,230
2015-05-13 2015-05-11 B Purchase Merck Capital Ventures LLC Large shareholder
167,343 +28.4%
14.00
US$2,342,802 		167,343 +28.4% 14.00 US$2,342,802
2015-05-13 2015-05-11 B Purchase GLAXOSMITHKLINE PLC Large shareholder
365,106 +inf%
14.00
US$5,111,484 		365,106 +inf% 14.00 US$5,111,484
2015-05-12 2015-05-11 B Purchase Novo A/S Large shareholder
365,106 +39.9%
14.00
US$5,111,484 		365,106 +39.9% 14.00 US$5,111,484
Explore more

More insider trading research around HTG Molecular Diagnostics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America